Asthma And Microbes: When You’re Exposed May Matter More Than How Much

Exposure to more germs may backfire for adult asthma sufferers

For years, researchers and parents alike have operated on a comforting premise: let kids play in the dirt, and they will be less likely to develop asthma and allergies. Now, however, a mouse study from Cornell University suggests that logic may not extend to adults. For grown immune systems suddenly flooded with a wide variety of new germs, the effect may worsen allergic airway inflammation under certain conditions.

Adult mice exposed to a broad range of microbes did not develop stronger defenses against allergic asthma. They developed worse disease, and the resulting inflammation proved significantly harder to treat with standard medications. Published in The Journal of Immunology, the study adds a major asterisk to the hygiene hypothesis, one of the most influential ideas in allergy research: timing appears to matter enormously, and what works for a child may not work the same way for an adult.

“Increasing exposure to diverse microbes as adults likely exacerbates the development of allergic airway inflammation, whereas this was not observed when exposure occurred at birth,” the researchers wrote. That finding raises pointed questions about how scientists have been applying the hygiene hypothesis, particularly in populations where microbial environments shift later in life.

How Researchers Put the Hygiene Hypothesis to the Test

Cornell researchers used three groups of mice to see how the timing of microbial exposure shapes asthma risk. One group was raised in standard sterile lab conditions, with minimal exposure to bacteria or other microbes. These are the animals used in most immunology research, and their immune systems in some ways resemble newborn immune systems.

A second group was created by moving adult lab mice into shared cages with pet store mice, which carry a wide range of bacteria, viruses, and other organisms from the outside world. After several weeks together, blood monitoring confirmed these animals had developed higher levels of memory T cells, a trait that more closely resembles adult human immune systems. Researchers called this group pet store-exposed, or PSE mice.

For a third group, breeding pairs of lab mice were cohoused with pet store mice before giving birth, so their pups grew up surrounded by diverse microbes from day one. These were called BiPSE mice, and they represented the early-life exposure scenario at the heart of the hygiene hypothesis.

All three groups were then exposed to house dust mite extract, a standard way to trigger allergic airway disease in mice that closely mirrors human asthma. Lung tissue, immune cell counts, and blood markers were analyzed afterward.

Adult Microbial Exposure Made Asthma Worse, Not Better

Among adult PSE mice, the results cut directly against the hygiene hypothesis. Compared to standard lab mice given the same allergen challenge, PSE mice developed more severe lung inflammation. Total lung cell counts and T cell numbers were measurably higher. A specific immune cell type called a Th17 cell was also markedly elevated. Th17 cells drive a pattern of airway inflammation associated with more severe, harder-to-treat asthma.

IgE levels in the blood, a well-established marker of allergic sensitization, were elevated in PSE mice and associated with microbial exposure even before any allergen was introduced.

Standard Asthma Drugs Lost Their Edge

Perhaps the most clinically relevant finding involved how PSE mice responded to dexamethasone, a corticosteroid routinely prescribed for moderate to severe asthma. In standard lab mice, dexamethasone significantly reduced lung cell counts, Th17 levels, and neutrophils, the white blood cells that flood inflamed airways. In PSE mice, the same treatment had little effect on several of those inflammatory measures. Eosinophils, another type of inflammatory cell that accumulates in allergic airways, were similarly unresponsive to treatment in PSE mice.

The pattern closely resembles steroid-resistant asthma, one of the most difficult forms of the disease to manage. Whether a comparable dynamic could occur in humans whose microbial environments shift dramatically in adulthood, through a move, new pets, or changes in medication, remains an open question, but it is one worth taking seriously.

What the Hygiene Hypothesis Gets Wrong About Adults

Mice born into microbial diversity, the BiPSE group, produced a notably different result. When challenged with house dust mite, their lung inflammation, T cell profiles, and eosinophil levels were comparable to standard lab mice. The dangerous inflammatory cascade seen in adult-exposed animals simply did not materialize.

Researchers suggest that early-life microbial exposure may allow tolerance mechanisms to develop before allergy risk solidifies. Exposure in adulthood may arrive too late for that process to work in the same way.

That age-dependent difference is what the hygiene hypothesis, as it is commonly applied, fails to capture. “Our findings that mice exposed to conditions of broader microbial diversity exhibit elevated AAD is contrary to what has been proposed by the hygiene hypothesis,” the authors wrote. Microbial diversity, in other words, is not inherently protective. When it arrives matters just as much as whether it arrives at all.

The study has limitations. All experiments were conducted in mice, and mouse biology does not always translate to humans. Researchers did not fully map which specific microbes the pet store mice carried, leaving open the possibility that particular organisms, rather than diversity overall, were the driving factor. Sample sizes in some groups were also small.

Still, for anyone studying why allergy rates keep rising in the developed world, this study offers a meaningful corrective. Dirtier is not automatically better. For adult immune systems encountering a wave of new microbes, it may actually be worse.

---

Disclaimer: This study was conducted in mice. The findings do not establish that microbial exposure causes worsened asthma in humans. Further research in human populations is needed before any clinical or behavioral conclusions can be drawn.

---